What is the generic name?

SELUMETINIB

What is the Trade Name for SELUMETINIB?

KOSELUGO

What are the Indications for SELUMETINIB?

• 1 INDICATIONS AND USAGE KOSELUGO is indicated for the treatment of pediatric patients 2 years of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN). KOSELUGO is a kinase inhibitor indicated for the treatment of pediatric patients 2 years of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN). ( 1 )

References: https://open.fda.gov/